GMED·Globus Medical Inc. Class A
GMED|Analyst Targets
GMED|Insider Trading
GMED|Fundamentals
GMED|Earnings Snapshot
EPS
| Qtr | Est | Actual | +/− |
|---|---|---|---|
| Q3'26 | $1.20 | - | - |
| Q3'25 | $0.78 | $1.18 | +51.1% |
Revenue
| Qtr | Est | Actual | +/− |
|---|---|---|---|
| Q3'26 | $808M | - | - |
| Q3'25 | - | $769M | - |
GMED|Monthly Returns
Market Data
GMED Stock Snapshot
- Market cap
- 10.15B
- P/E ratio
- 19.0
- Day range
- $75.84 – $77.65
- News sentiment
- 64/100 · Bullish
- Analyst target
- $100.92 (+32.0%)
- Consensus
- Buy · 25 analysts
This is a pause rather than a turn for GMED - the signals are mixed by construction. Earnings and guidance carry more weight than macro data at this capitalisation.
Behaviour On Record
What GMED's own history says about today's numbers
- Realized volatility (21d)
- 31.4% 59th pct
- Below its peak
- -22.7%
- vs 200-day average
- -9.6%
- Up days (1y)
- 47%
Globus Medical Inc. Class A is currently running 31.4% annualised volatility over the last 21 sessions. Measured against GMED's own 13 years of daily returns rather than a market-wide average, that is the 59th percentile — close to its own typical level, against a typical reading of 28.9%. The distinction matters because a number that looks calm for one stock is turbulent for another, and the absolute figure on its own tells you neither.
GMED is trading -22.7% below its running peak. Across 12 full years on file, its median worst-drawdown-in-a-year was -27.2%, and the deepest was -45.0% in 2023. The current pullback is therefore shallower than what this stock gives back in a typical year, which is context worth having before treating it as a dislocation.
Price sits -9.6% from its 200-day moving average. Against every other day in its history, that gap ranks at the 19th percentile — a narrower gap than it typically runs. Over the past year GMED closed higher on 47% of sessions, and it is currently 2 sessions into a rising streak.
On October specifically: over 13 years of records, GMED finished the month higher 9 of 13 times, with a median return of +4.7% and an average of +3.9%. Its strongest month historically has been November at +8.6% on average, its weakest September at -3.1%. Seasonality is a weak signal on its own — a decade is a small sample and regimes change — but it is a real distribution rather than a rule of thumb.
Overnight risk is measurable too: GMED has opened more than 2% away from the prior close in 194 of 3,267 sessions (5.9% of the time), with the largest gaps running +17.5% and -13.0%. For anyone holding through an event, that rate is a better guide to overnight exposure than the intraday range.
All figures computed from 3,268 daily closes between 2013-10-07 and 2026-10-05, split-adjusted, recomputed daily. Percentiles are against GMED's own 13-year history, not a peer group or index.
Sector Rotation
Is money rotating into or out of GMED's sector?
Globus Medical Inc. Class A sits in the Health Care sector, currently ranked 8th of 12 GICS sectors by relative-strength rotation score (lagging).
- Sector rank
- #8 of 12
- Sector state
- Lagging
- Sector rotation score
- 0
Analyst Rating Changes
Are analysts turning bullish or bearish on GMED?
RBC Capital most recently reiterated its rating on Globus Medical Inc. Class A to Outperform on Oct 1, 2026 with a price target of $85 (from $115). Over the last 90 days, coverage has run 0 upgrades against 0 downgrades, a net mixed lean.
- Latest action
- RBC Capital — Outperform
- 90-day upgrades
- 0
- 90-day downgrades
- 0
- Net rating momentum
- 0
Held by These ETFs
News Sentiment Analysis
Sentiment gathered from recent headlines
Recent News Coverage
Most recent articles, ranked by recency (click to expand).
Technical Analysis
Real-time indicators across multiple timeframes
| Member | Chamber | State | Type | Amount | Traded | Filed |
|---|---|---|---|---|---|---|
| Gilbert Cisneros | House | CA31 | ▲ Buy | $15K - $50K | 2026-08-19 | 2026-09-10 |
| Lisa McClain | House | MI09 | ▼ Sell | $1K - $15K | 2025-07-10 | 2025-08-13 |
| Josh Gottheimer | House | NJ05 | ▼ Sell | $1K - $15K | 2025-04-09 | 2025-05-14 |
| Thom Tillis | Senate | NC | ▼ Sell | $1K - $15K | 2015-02-13 | 2015-02-26 |